{A figure is presented}Nodal Ratios in Node-Positive Breast Cancer-Long-Term Study to Clarify Discrepancy of Role of Supraclavicular and Axillary Regional Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 662-666

  Tai, Patricia ^a   Joseph, Kurian ^b   Sadikov, Evgeny ^a   Mahmood, Shazia ^a   Lien, Francis ^a   Yu, Edward ^c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Breast cancer; Nodal ratio; Node positive; Regional radiotherapy; Survival

Indexed keywords

PATHOLOGY; RADIOTHERAPY; TUMORS;

BREAST CANCER; NODAL RATIOS; REGIONAL RADIOTHERAPY; SURVIVAL RATES;

ONCOLOGY;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANADA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR VOLUME; AXILLA; BREAST TUMOR; CLAVICLE; COMPARATIVE STUDY; LONGITUDINAL STUDY; LYMPH NODE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTOR; STATISTICS; SURVIVAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CLAVICLE; FEMALE; HUMANS; LONGITUDINAL STUDIES; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SASKATCHEWAN; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34249278468     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.057     Document Type: Article

References (21)

1. Kunkler I.H., Prescott R.J., Williams L.J., et al. When may adjuvant radiotherapy be avoided in operable breast cancer?. Clin Oncol (R Coll Radiol) 18 (2006) 191-199
2. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Eng J Med 337 (1997) 956-962
3. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
4. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
5. Recht A., Edge S.B., Solin L.J., et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 (2001) 1539-1569
6. Griem K.L., Henderson I.C., Gelman R., et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5 (1987) 1546-1555
7. McArdle C.S., Crawford D., Dykes E.H., et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73 (1986) 264-266
8. Woodward W.A., Vinh-Hung V., Nieto Y., et al., International Nodal Ratio Working Group. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24 (2006) 2910-2916
9. Axelsson C.K., Mouridsen H.T., Zedeler K., et al. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. Eur J Cancer 28A (1992) 1415-1418
10. Ciatto S., Pacini P., DelTurco M.R., et al. Patterns of axillary metastases in breast cancer. Radiother Oncol 5 (1986) 91-94
11. Fisher B., Wolmark N., Bauer M., et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
12. Kiricuta C.I., and Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 69 (1992) 2496-2501
13. Rose C.M., Botnick L.E., Weinstein M., et al. Axillary sampling in the definitive treatment of breast cancer by radiation therapy and lumpectomy. Int J Radiat Oncol Biol Phys 9 (1983) 339-344
14. Truong P., Berthelet E., Lee J., et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 103 (2005) 2006-2014
15. Joslyn S.A., and Konety B.R. Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treatment 91 (2005) 11-18
16. Sobin L.H., and Wittekind C.H. TNM classification of malignant tumors. 5th ed. (1997), Wiley-Liss, New York 123-130
17. Grills I.S., Kestin L.L., Goldstein N., et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 56 (2003) 658-670
18. Truong P.T., Olivotto A., Kader H.A., et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 658-670
19. Katz A., Strom E.A., Buchholz T.A., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 18 (2000) 2817-2827
20. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
21. Fowble B. Postmastectomy radiation in patients with one to three positive axillary nodes receiving adjuvant chemotherapy: An unresolved issue. Semin Radiat Oncol 9 (1999) 230-240